Strategic Global Advisors’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $861K | Buy |
17,868
+10,631
| +147% | +$496K | 0.14% | 120 |
|
|
2025
Q4 | $351K | Buy |
+7,237
| New | +$359K | 0.05% | 133 |
|
|
2024
Q3 | – | Sell |
-2,850
| Closed | -$250K | – | 157 |
|
|
2024
Q2 | $250K | Sell |
2,850
-2,388
| -46% | -$115K | 0.05% | 131 |
|
|
2024
Q1 | $255K | Sell |
5,238
-2,107
| -29% | -$103K | 0.06% | 132 |
|
|
2023
Q4 | $365K | Buy |
7,345
+1,496
| +26% | +$73.2K | 0.08% | 133 |
|
|
2023
Q3 | $314K | Buy |
5,849
+2,033
| +53% | +$108K | 0.05% | 131 |
|
|
2023
Q2 | $206K | Buy |
+3,816
| New | +$205K | 0.03% | 138 |
|
|
2023
Q1 | – | Sell |
-9,030
| Closed | -$437K | – | 151 |
|
|
2022
Q4 | $437K | Sell |
9,030
-78
| -0.9% | -$3.42K | 0.07% | 116 |
|
|
2022
Q3 | $346K | Buy |
9,108
+421
| +5% | +$18.8K | 0.06% | 124 |
|
|
2022
Q2 | $435K | Sell |
8,687
-134
| -2% | -$7.11K | 0.07% | 121 |
|
|
2022
Q1 | $453K | Buy |
8,821
+154
| +2% | +$7.95K | 0.07% | 116 |
|
|
2021
Q4 | $1.96M | Sell |
8,667
-34,375
| -80% | -$1.7M | 0.25% | 102 |
|
|
2021
Q3 | $2.08M | Sell |
43,042
-136
| -0.3% | -$6.92K | 0.3% | 98 |
|
|
2021
Q2 | $2.27M | Buy |
43,178
+255
| +0.6% | +$13.3K | 0.41% | 86 |
|
|
2021
Q1 | $2.12M | Buy |
42,923
+13,054
| +44% | +$627K | 0.38% | 96 |
|
|
2020
Q4 | $1.45M | Buy |
29,869
+2,574
| +9% | +$127K | 0.26% | 111 |
|
|
2020
Q3 | $1.37M | Sell |
27,295
-172
| -0.6% | -$8.86K | 0.26% | 100 |
|
|
2020
Q2 | $1.4M | Buy |
+27,467
| New | +$1.33M | 0.3% | 90 |
|
|
2018
Q4 | – | Sell |
-8,574
| Closed | -$383K | – | 197 |
|
|
2018
Q3 | $383K | Sell |
8,574
-2,124
| -20% | -$90.7K | 0.12% | 139 |
|
|
2018
Q2 | $429K | Hold |
10,698
| – | – | 0.11% | 130 |
|
|
2018
Q1 | $429K | Buy |
10,698
+212
| +2% | +$8.82K | 0.15% | 119 |
|
|
2017
Q4 | $451K | Buy |
10,486
+24
| +0.2% | +$1.11K | 0.15% | 111 |
|
|
2017
Q3 | $521K | Buy |
10,462
+1,830
| +21% | +$88.6K | 0.2% | 103 |
|
|
2017
Q2 | $414K | Buy |
8,632
+54
| +0.6% | +$2.58K | 0.15% | 111 |
|
|
2017
Q1 | $388K | Buy |
8,578
+528
| +7% | +$22.4K | 0.14% | 127 |
|
|
2016
Q4 | $326K | Hold |
8,050
| – | – | 0.12% | 128 |
|
|
2016
Q3 | $336K | Sell |
8,050
-9
| -0.1% | -$361 | 0.13% | 129 |
|
|
2016
Q2 | $337K | Hold |
8,059
| – | – | 0.13% | 126 |
|
|
2016
Q1 | $324K | Buy |
8,059
+1,620
| +25% | +$65.1K | 0.14% | 123 |
|
|
2015
Q4 | $275K | Hold |
6,439
| – | – | 0.12% | 119 |
|
|
2015
Q3 | $306K | Sell |
6,439
-2,185
| -25% | -$111K | 0.15% | 102 |
|
|
2015
Q2 | $427K | Buy |
8,624
+4,180
| +94% | +$212K | 0.25% | 91 |
|
|
2015
Q1 | $220K | Hold |
4,444
| – | – | 0.16% | 122 |
|
|
2014
Q4 | $202K | Buy |
+4,444
| New | +$216K | 0.18% | 128 |
|
Other funds holding SNY
MIP
Strategic Global Advisors's SNY Position: Q1 2026 in Review
Strategic Global Advisors increased its Sanofi (SNY) stake by 147% in Q1 2026, buying an estimated $496K and bringing the position to 17,868 shares worth $861K. The position accounts for 0.14% of the portfolio, ranked #120.
Strategic Global Advisors first reported a position in SNY in Q4 2014 and has held it in 34 quarters since. The position peaked at $2.27M in Q2 2021. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.
- Strategic Global Advisors held 17,868 shares of Sanofi worth $861K as of Q1 2026.
- Strategic Global Advisors bought 10,631 Sanofi shares in Q1 2026, an estimated $496K.
- Sanofi made up 0.14% of Strategic Global Advisors's portfolio in Q1 2026, its #120 holding.
- Strategic Global Advisors first reported a position in Sanofi in Q4 2014 and has held it in 34 quarters since.
- Strategic Global Advisors's Sanofi position peaked at $2.27M in Q2 2021.
- 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.
Based on Strategic Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.